Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMAD9 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-07 |
mRNA | ATP2B3 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | MICAL1 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | IRAK3 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | LAMP5 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-07 |
mRNA | SYP | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | SMIM17 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | RCOR3 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
mRNA | CLTCL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |